Drug Trio Improves Odds Against Advanced Pancreatic Cancer

THURSDAY, Oct. 3, 2019 -- A three-drug chemo cocktail appears to shrink tumors and improve survivorship among pancreatic cancer patients, a new, small study shows.

Tumors substantially shrank for just over 71% of patients treated with a three-drug regimen of nab-paclitaxel, gemcitabine and platinum-based cisplatin, the researchers found.

Scientists Find Unsafe Levels of Known Carcinogen in Menthol E-Cigarettes

MONDAY, Sept. 16, 2019 -- As doctors race to determine what is causing sudden and severe lung illnesses among some vapers, new research discovers dangerously high levels of a known carcinogen in menthol-flavored electronic cigarettes.

The chemical (pulegone) is used as a menthol and mint flavoring, even though it was recently banned in foods, the researchers said.

America's Obesity Epidemic May Mean Some Cancers Are Striking Sooner

WEDNESDAY, Aug. 14, 2019 -- Since the turn of the century, American obesity rates have skyrocketed. And now a new study indicates that as the nation's waistlines expand, cancers long linked to obesity are striking the middle-aged more than ever before.

The finding follows a review of data on more than 6 million white, black and Hispanic cancer patients diagnosed between 2000 and 2016.

Drug Offers Hope Against a Tough-to-Treat Blood Cancer

WEDNESDAY, Aug. 21, 2019 -- Patients with a form of blood cancer known as multiple myeloma who haven't responded to other therapies might have a new weapon against the disease, researchers say.

A drug called selinexor appeared to help patients with the blood and bone marrow cancer, according to a clinical trial involving 122 people.